Dixon P H, van Mil S W C, Chambers J, Strautnieks S, Thompson R J, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson L-A, Marschall H-U, Molokhia M, Moore G E, Linton K J, Williamson C
Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, UK.
Gut. 2009 Apr;58(4):537-44. doi: 10.1136/gut.2008.159541. Epub 2008 Nov 5.
Intrahepatic cholestasis of pregnancy (ICP) has a complex aetiology with a significant genetic component. ABCB11 encodes the bile salt export pump (BSEP); mutations cause a spectrum of cholestatic disease, and are implicated in the aetiology of ICP.
ABCB11 variation in ICP was investigated by screening for five mutant alleles (E297G, D482G, N591S, D676Y and G855R) and the V444A polymorphism (c.1331T>C, rs2287622) in two ICP cohorts (n = 333 UK, n = 158 continental Europe), and controls (n = 261) for V444A. PCR primers were used to amplify and sequence patient and control DNA. The molecular basis for the observed phenotypes was investigated in silico by analysing the equivalent residues in the structure of the homologous bacterial transporter Sav1866.
E297G was observed four times and D482G once. N591S was present in two patients; D676Y and G855R were not observed. The V444A polymorphism was associated with ICP (allelic analysis for C vs T: OR 1.7 (95% CI 1.4 to 2.1, p<0.001)). In addition, CC homozygotes were more likely to have ICP than TT homozygotes: OR 2.8 (95% CI 1.7 to 4.4 p<0.0001). Structural analyses suggest that E297G and D482G destabilize the protein fold of BSEP. The molecular basis of V444A and N591S was not apparent from the Sav1866 structure.
Heterozygosity for the common ABCB11 mutations accounts for 1% of European ICP cases; these two mutants probably reduce the folding efficiency of BSEP. N591S is a recurrent mutation; however, the mechanism may be independent of protein stability or function. The V444A polymorphism is a significant risk factor for ICP in this population.
妊娠期肝内胆汁淤积症(ICP)病因复杂,具有重要的遗传因素。ABCB11编码胆盐输出泵(BSEP);突变会引发一系列胆汁淤积性疾病,并与ICP的病因有关。
通过筛查两个ICP队列(英国333例,欧洲大陆158例)中的五个突变等位基因(E297G、D482G、N591S、D676Y和G855R)以及V444A多态性(c.1331T>C,rs2287622),并在对照组(261例)中检测V444A,研究ICP中的ABCB11变异。使用PCR引物扩增并测序患者和对照的DNA。通过分析同源细菌转运蛋白Sav1866结构中的等效残基,在计算机上研究观察到的表型的分子基础。
观察到4次E297G,1次D482G。两名患者存在N591S;未观察到D676Y和G855R。V444A多态性与ICP相关(C与T的等位基因分析:比值比1.7(95%可信区间1.4至2.1,p<0.001))。此外,CC纯合子比TT纯合子更易患ICP:比值比2.8(95%可信区间1.7至4.4,p<0.0001)。结构分析表明,E297G和D482G会破坏BSEP的蛋白质折叠。从Sav1866结构中无法明确V444A和N591S的分子基础。
常见ABCB11突变的杂合性占欧洲ICP病例的1%;这两个突变体可能会降低BSEP的折叠效率。N591S是一个反复出现的突变;然而,其机制可能与蛋白质稳定性或功能无关。V444A多态性是该人群中ICP的一个重要风险因素。